Cynata Therapeutics LimitedASX: CYP

Cymerus MSCs Effective in Preclinical Lung Disease Study

Sep 7, 2020 at 4:03 AM UTC · Issued by Cynata Therapeutics Limited

Cynata Therapeutics Ltd has released a press release.

View Attachment